A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/114
A61K 35/14 (2006.01) A61K 35/16 (2006.01) A61M 1/34 (2006.01) A61M 1/36 (2006.01)
Patent
CA 1309020
19 EXTRACORPOREAL REMOVAL OF IMMUNOGLOBULIN-G AND CIRCULATING IMMUNE COMPLEXES Abstract of the Disclosure A method for removing immunoglobulin-G and immune complexes from blood comprises withdrawing a small, discrete volume of blood from a patient, separating the blood volume into its cellular and plasma components, immediately reinfusing the cellular components to the patient, passing the plasma components through a protein A immunoadsorbent, and reinfusing the treated plasma to the patient. By treating relatively small volumes of blood and employing an inert, non-colloidal protein A immunoadsorbent, typically protein A covalently bound to microcrystalline silica, greatly reduced side effects are observed without loss of efficacy. In treatment of cancer and autoimmune diseases, the treatment protocol is repeated periodically, usually at least once per week for a period of four weeks or longer. 10094-14/PA JMH010
552327
Balint Joseph P.
Jones Frank R.
Snyder Harry W. Jr.
Fetherstonhaugh & Co.
Imre Corporation
LandOfFree
Extracorporeal removal of immunoglobulin-g and circulating... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extracorporeal removal of immunoglobulin-g and circulating..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracorporeal removal of immunoglobulin-g and circulating... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1323804